Posted on

Agents for the management of Pseudomonas aeruginosa infection

Volume 5, Issue 14.

In this issue we are joined by Dr. Shawn Aaron of University of Ottawa in Ontario, Canada. Dr. Aaron will discuss infection in patients with optimal therapy of chronic Pseudomonas aeruginosa cystic fibrosis, describe the pathophysiology of pulmonary exacerbations associated with Pseudomonas infection in patients with cystic fibrosis, and evaluate the optimal choice of antibiotics to treat Pseudomonas-associated pulmonary exacerbations in patients with cystic fibrosis.

Podcast (ecystic): Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS

Posted on

New Insights into Lifestyle Modification

Volume 1, Issue 4.

Ellen M. Mowry, MD, MCR covers the important topic of New Insights into Lifestyle Modification in the format of case-study scenarios for the clinical practice.

To read a companion newsletter click here.

Podcast (emultiplesclerosis): Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS

Posted on

Benefits of CFTR Modification Beyond FEV1 Improvement

Volume 5, Issue 12.

In this issue of eCysticfibrosis Review Dr. Chris Goss of the University of Washington Medical Center. Dr. Goss discusses the benefits of CFTR modification beyond Fev1 improvement through the use of patient-cases.

Podcast (ecystic): Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS

Posted on

Personalizing DMT Regimens/The Risks of Medication Non-Adherence

Volume 1, Issue 2.

Arun Venkatesan, MD, PhD and Scott Douglas Newsome, DO cover the important topics of personalizing DMT regimens and the risk of medication non-adherence in the format of case-study scenarios for the clinical practice.

To read a companion newsletter click here.

Podcast (emultiplesclerosis): Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS

Posted on

The Effects of CFTR-modifying Therapies

Volume 5, Issue 10.

In this issue of eCystifibrosis Review we will be join by Dr. Stuart Elborn of Queens University in Belfast, Northern Ireland. Dr. Elborn discusses the effects of CFTR-Modifying Therapies. He will present three patient-case scenarios and identify appropriate treatment options.

Podcast (ecystic): Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS

Posted on

Optimizing Nutrition in Individuals with Cystic Fibrosis

Volume 5, Issue 8.

In this issue of eCysticFibrosis Review Dr. John Pohl discuses how to optimize nutrition in individuals with CF. Through patient case-scenarios he applies best practices to achieve optimal nutrition using PERT dosing.

Podcast (ecystic): Play in new window | Download

Subscribe: Apple Podcasts | Android | RSS